Stock LNTH LANTHEUS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Market Closed - Nasdaq
Other stock markets
 21:00:00 09/05/2024 BST 		5-day change 1st Jan Change
75.9 USD +1.87% Intraday chart for Lantheus Holdings, Inc. -2.92% +22.42%
05-03 Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating MT
05-02 Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lantheus Shares Rise After Reporting Higher Q1 Adjusted Earnings, Revenue; 2024 Guidance Raised
MT
Lantheus to Seek M&A Opportunities
CI
Lantheus Holdings, Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024
CI
Lantheus Holdings, Inc. Revises Revenue Guidance for the Full Fiscal Year 2024
CI
(LNTH) LANTHEUS HOLDINGS Sees Q2 EPS Range $1.81 - $1.86
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 Revenue $370M
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q1 EPS $1.69
MT
Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Lantheus Holdings Says FDA Approves Expanded Use of Definity in Pediatric Patients
MT
Lantheus Holdings, Inc. Announces the FDA Approval of Definity (Perflutren Lipid Microsphere) for Pediatric Patients
CI
Lantheus Holdings Q4 Adjusted Earnings, Revenue Climb; Issues Q1, Full Year Guidance; Shares Rise
MT
(LNTH) LANTHEUS HOLDINGS Forecasts Q1 EPS Range $1.50 - $1.54
MT
(LNTH) LANTHEUS HOLDINGS Forecasts Fiscal Year 2024 EPS Range $6.50 - $6.70
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q4 Revenue $354M
MT
Earnings Flash (LNTH) LANTHEUS HOLDINGS Reports Q4 EPS $1.75
MT
Lantheus Holdings, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024
CI
Lantheus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Lantheus Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Lantheus Holdings, Inc. Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
CI
Lantheus Sued by Novartis Entities for Patent Infringement
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LNTH Stock
  4. News Lantheus Holdings, Inc.
  5. Highlights